Position in SNY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$223,709
+$36,799 QoQ
Shares Held
5,244
+36.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#471
of 712 holders
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lloyd Advisory Services, LLC. holds $1,085,044 across 10 Drug Manufacturers - General names. SNY ranks #3 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,113 | $280,075 | |
| 2 | PFE |
Pfizer Inc
|
9,335 | $224,786 | |
| 3 | SNY |
Sanofi
This page
|
5,244 | $223,709 | |
| 4 | MRK |
Merck & Co., Inc.
|
901 | $115,778 | |
| 5 | AMGN |
Amgen Inc
|
314 | $113,705 | |
| 6 | JNJ |
Johnson & Johnson
|
259 | $65,778 | |
| 7 | LLY |
ELI LILLY & Co
|
32 | $38,381 | |
| 8 | AZN |
Astrazeneca PLC
|
105 | $19,910 |
All Filings in SNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $223,709 | 5,244 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $186,910 | 3,857 | Shares | Sole | 2026-02-06 | |
| 2025-03-31 | $227,108 | 4,095 | Shares | Sole | 2025-04-14 | |
| 2024-09-30 | $230,174 | 3,994 | Shares | Sole | 2024-10-10 | |
| No filing history on record for this holder in this stock. | ||||||